A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321
Clinical trial NCT00354861 · COMPLETED
Trial details
- NCT number
- NCT00354861
- Sponsor
- Immutep S.A.S.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2005-11-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.